On October 1, NCHC will host a virtual event bringing together expert perspectives on the Trump and Biden presidential campaigns to share the candidates’ plan to reinvent our nation’s health care system for our patients, providers, and communities. The conversation will be moderated by Noam Levey, a national health care reporter with the Los Angeles Times, followed […]
Another Looming Catastrophe: The Lawsuit Against the Affordable Care Act
The Administration’s continued pursuit to strike down the Affordable Care Act (ACA) in the courts openly undermines affordable health insurance coverage during the pandemic, threatening our public health response and economic recovery. The COVID-19 pandemic has caused unprecedented and widespread damage to our health and economy Since January, more than 3 million people have been […]
The Pharmaceutical Pricing Debate in the U.S.: Comparing the Current U.S. Situation to Germany
John Rother President, National Coalition on Health Care Introduction The price of pharmaceuticals has been a top policy issue in the U.S., especially since the introduction of the $1000 per pill Hep C drug Sovaldi in 2017. Drug prices are a top concern for Americans going into the fall elections. The issue is driven by […]
H.R. 1425: The Patient Protection and Affordable Care Enhancement Act
House Democrats unveiled H.R. 1425 which would expand and protect key elements of the Affordable Care Act (ACA). Key provisions of H.R. 1425 include expanding subsidies and eligibility requirements for state-level exchanges. Importantly, states would have the ability to expand premium tax credits beyond 400% of the federal poverty line. H.R. 1425 also fixes the […]
Stressed Health Care System Today Could Result in Better Care Tomorrow
Today’s health care institutions are stretched to capacity and beyond by the COVID-19 crisis. But like physical exercise, it’s possible that this stress can lead us to a stronger system longer-term. This depends, of course, on how we respond to the shortcomings revealed by our slow responses to the pandemic.From my decades in health policy, […]
Has “Value” in Health Care Stagnated?
The future of value-based purchasing (VBP) is uncertain. Current models have theoretical promise, but critics point to minimal achievements. Despite the rhetoric around paying for value over volume, the percent of health care spending involved in pay-for-performance contracts has stagnated or declined. In addition, the polled enthusiasm among health care industry leaders for value-based purchasing is declining. […]
Multi-stakeholder Coalition Applauds Legislation to Provide Affordable Health Care to All Americans
Washington, DC – Yesterday, Speaker Nancy Pelosi (D-CA), Majority Leader Steny Hoyer (D-MD), Energy & Commerce Committee Chairman Frank Pallone Jr. (D-NJ), Ways & Means Committee Chairman Richard Neal (D-MA), and Education & Labor Committee Chairman Bobby Scott (D-VA) released a joint statement announcing that H.R. 3, the Lower Drug Costs Now Act, will come to a floor vote next week. The National Coalition on Health Care supports H.R. 3 to lower prescription drug prices and urges its swift passage to the U.S. Senate. […]
NCHC Writes Letter to Senator Alexander on Health Care Costs
On February 28th, NCHC wrote a letter to the Senate HELP Committee addressed to Senator Alexander. The letter was in response to a request from Senator Alexander asking for policy recommendations to address the rising costs of health care. You can read the entire letter here.
NCHC Memo on Trump Administration’s “Most-Favored-Nation” Executive Order
On July 24, President Trumped signed a series of executive order (EOs) focused on reducing Medicare beneficiary and program spending on prescription drugs. One executive order, the details of which were not immediately released, would set prices for drugs in Medicare Part B to no more than the prices paid by a basket of other […]
NCHC Statement On The Trump Administration’s “Most-Favored-Nation” Drug Pricing Executive Order
The National Coalition on Health Care (NCHC) opposes the Administration’s approach to address drug pricing through the “Most-Favored-Nation” (MFN) executive order released yesterday. The executive order rightly recognizes the urgency of addressing exorbitant drug prices, for the sake of the Medicare program and for its beneficiaries, but we encourage the White House to apply this […]
The German Pharmaceutical Model: Could it Work in the U.S.?
As drug prices continue to rise, policymakers debate drug pricing reform. The United States spends more on prescription drugs per capita than any other developed country. For example, Germany spends an average of $685 on retail prescription drugs per capita, while the United States spends over $1,000. Yet, Germany has a similar health care system […]
NCHC Statement on CARES 2.0 Act
Yesterday, negotiations over a fourth major COVID-19 relief package began in earnest after the Senate released the Health, Economic Assistance, Liability Protection and Schools (HEALS) Act. The National Coalition on Health Care (NCHC) applauds some elements of the bill, including critical funding for schools and nursing homes, which is necessary for both our economic recovery […]
- 1
- 2
- 3
- …
- 80
- Next Page »